vs
高乐氏（CLX）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是高乐氏的1.3倍（$2.1B vs $1.7B），Roper Technologies净利率更高（15.8% vs 9.4%，领先6.4%），Roper Technologies同比增速更快（11.3% vs 0.3%），过去两年Roper Technologies的营收复合增速更高（10.5% vs -8.3%）
高乐氏是美国跨国企业，专业从事消费级与专业用途产品的生产及营销。2000年至2024年持续入选《财富》500强榜单，最新排名为第485位，旗下产品覆盖清洁护理、家居日用等多个品类，在全球消费市场拥有较高认可度。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
CLX vs ROP — 直观对比
营收规模更大
ROP
是对方的1.3倍
$1.7B
营收增速更快
ROP
高出11.0%
0.3%
净利率更高
ROP
高出6.4%
9.4%
两年增速更快
ROP
近两年复合增速
-8.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $2.1B |
| 净利润 | $157.0M | $331.0M |
| 毛利率 | 43.2% | 69.4% |
| 营业利润率 | — | 27.2% |
| 净利率 | 9.4% | 15.8% |
| 营收同比 | 0.3% | 11.3% |
| 净利润同比 | -15.6% | 842.6% |
| 每股收益（稀释后） | $1.29 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLXROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | $2.0B | $1.9B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.7B | $1.9B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.9B | $1.7B |
净利润CLXROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $157.0M | $428.4M | ||
| Q3 25 | — | $398.5M | ||
| Q2 25 | $332.0M | $378.3M | ||
| Q1 25 | $186.0M | $331.1M | ||
| Q4 24 | $193.0M | $462.3M | ||
| Q3 24 | $99.0M | $367.9M | ||
| Q2 24 | $216.0M | $337.1M |
毛利率CLXROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 43.2% | 69.5% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | 46.5% | 69.2% | ||
| Q1 25 | 44.6% | 68.7% | ||
| Q4 24 | 43.8% | 68.3% | ||
| Q3 24 | 45.8% | 69.2% | ||
| Q2 24 | 46.5% | 69.5% |
营业利润率CLXROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | — | 28.6% | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | 20.6% | 28.2% | ||
| Q1 25 | 15.2% | 27.9% | ||
| Q4 24 | 14.1% | 28.0% | ||
| Q3 24 | 10.0% | 28.1% | ||
| Q2 24 | 14.5% | 28.8% |
净利率CLXROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | 9.4% | 20.8% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | 16.7% | 19.5% | ||
| Q1 25 | 11.2% | 17.6% | ||
| Q4 24 | 11.4% | 24.6% | ||
| Q3 24 | 5.6% | 20.8% | ||
| Q2 24 | 11.4% | 19.6% |
每股收益（稀释后）CLXROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $1.29 | $3.97 | ||
| Q3 25 | — | $3.68 | ||
| Q2 25 | $2.68 | $3.49 | ||
| Q1 25 | $1.50 | $3.06 | ||
| Q4 24 | $1.54 | $4.29 | ||
| Q3 24 | $0.80 | $3.40 | ||
| Q2 24 | $1.74 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $227.0M | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $-125.0M | $18.8B |
| 总资产 | $5.6B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资CLXROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $227.0M | $297.4M | ||
| Q3 25 | — | $320.0M | ||
| Q2 25 | $167.0M | $242.4M | ||
| Q1 25 | $226.0M | $372.8M | ||
| Q4 24 | $290.0M | $188.2M | ||
| Q3 24 | $278.0M | $269.6M | ||
| Q2 24 | $202.0M | $251.5M |
总债务CLXROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.5B | — |
股东权益CLXROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $-125.0M | $19.9B | ||
| Q3 25 | — | $20.0B | ||
| Q2 25 | $321.0M | $19.6B | ||
| Q1 25 | $27.0M | $19.2B | ||
| Q4 24 | $-41.0M | $18.9B | ||
| Q3 24 | $60.0M | $18.5B | ||
| Q2 24 | $328.0M | $18.1B |
总资产CLXROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $5.6B | $34.6B | ||
| Q3 25 | — | $34.6B | ||
| Q2 25 | $5.6B | $33.2B | ||
| Q1 25 | $5.5B | $31.4B | ||
| Q4 24 | $5.6B | $31.3B | ||
| Q3 24 | $5.5B | $31.6B | ||
| Q2 24 | $5.8B | $29.8B |
负债/权益比CLXROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $507.0M |
| 自由现金流率自由现金流/营收 | — | 24.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLXROP
| Q1 26 | — | — | ||
| Q4 25 | — | $738.0M | ||
| Q3 25 | — | $869.5M | ||
| Q2 25 | $294.0M | $404.1M | ||
| Q1 25 | $286.0M | $528.7M | ||
| Q4 24 | $180.0M | $722.2M | ||
| Q3 24 | $221.0M | $755.4M | ||
| Q2 24 | $340.0M | $384.1M |
自由现金流CLXROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $219.0M | — | ||
| Q1 25 | $233.0M | — | ||
| Q4 24 | $127.0M | — | ||
| Q3 24 | $182.0M | — | ||
| Q2 24 | $259.0M | — |
自由现金流率CLXROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 14.0% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 13.6% | — |
资本支出强度CLXROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 4.3% | — |
现金转化率CLXROP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | 0.89× | 1.07× | ||
| Q1 25 | 1.54× | 1.60× | ||
| Q4 24 | 0.93× | 1.56× | ||
| Q3 24 | 2.23× | 2.05× | ||
| Q2 24 | 1.57× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLX
| Health And Wellness | $643.0M | 38% |
| Household | $419.0M | 25% |
| Lifestyle | $321.0M | 19% |
| Other | $290.0M | 17% |
ROP
暂无分部数据
